Layilin (LAYN) is a signature gene for tumor-specific Tregs and exhausted CD8+ T cells, and LAYN overexpression in CD8+ T cells suppressed the production of IFN-γ, suggesting that LAYN had an inhibitory effect on CD8+ T cells. This evidence concerns the gene LAYN and neoplasm.